Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis.
Stascheit F, Grittner U, Hoffmann S, Mergenthaler P, Schroeter M, Ruck T, Pawlitzki M, Blaes F, Kaiser J, Schara U, Della-Marina A, Thieme A, Hagenacker T, Jacobi C, Berger B, Urban PP, Knop KC, Schalke B, Lee DH, Kalischewski P, Wiendl H, Meisel A.
Stascheit F, et al. Among authors: urban pp.
J Neurol. 2023 Jan;270(1):1-12. doi: 10.1007/s00415-022-11389-0. Epub 2022 Sep 27.
J Neurol. 2023.
PMID: 36166068
Free PMC article.